Expanding the DNA-encoded library toolbox: identifying small molecules targeting RNA

Abstract DNA-encoded library (DEL) technology is a powerful tool for small molecule identification in drug discovery, yet the reported DEL selection strategies were applied primarily on protein targets in either purified form or in cellular context. To expand the application of this technology, we e...

Full description

Saved in:
Bibliographic Details
Published inNucleic acids research Vol. 50; no. 12; p. e67
Main Authors Chen, Qiuxia, Li, You, Lin, Chunrong, Chen, Liu, Luo, Hao, Xia, Shuai, Liu, Chuan, Cheng, Xuemin, Liu, Chengzhong, Li, Jin, Dou, Dengfeng
Format Journal Article
LanguageEnglish
Published England Oxford University Press 08.07.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract DNA-encoded library (DEL) technology is a powerful tool for small molecule identification in drug discovery, yet the reported DEL selection strategies were applied primarily on protein targets in either purified form or in cellular context. To expand the application of this technology, we employed DEL selection on an RNA target HIV-1 TAR (trans-acting responsive region), but found that the majority of signals were resulted from false positive DNA–RNA binding. We thus developed an optimized selection strategy utilizing RNA patches and competitive elution to minimize unwanted DNA binding, followed by k-mer analysis and motif search to differentiate false positive signal. This optimized strategy resulted in a very clean background in a DEL selection against Escherichia coli FMN Riboswitch, and the enriched compounds were determined with double digit nanomolar binding affinity, as well as similar potency in functional FMN competition assay. These results demonstrated the feasibility of small molecule identification against RNA targets using DEL selection. The developed experimental and computational strategy provided a promising opportunity for RNA ligand screening and expanded the application of DEL selection to a much wider context in drug discovery.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors wish it to be known that, in their opinion, the first three authors should be regarded as Joint First Authors.
ISSN:0305-1048
1362-4962
DOI:10.1093/nar/gkac173